Conference Coverage

Conference Coverage

Nivo/ipi shrinks early NSCLC before surgery

CHICAGO – Among patients who went on to resection, 44% of those who had received neoadjuvant nivolumab and ipilimumab had a major pathological...

Conference Coverage

Survival exceeds 90% in transplant for SCD

FORT LAUDERDALE, FLA. — A pilot study has shown one-year overall survival rates exceeding 90% for bone marrow transplants in adults with severe...

Pages